Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01386476 · ClinicalTrials.gov registry record
(18F)FCWAY and the Blood-Brain Barrier
A clinical trial of Drug Resistance, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT01386476: Completed study of Drug Resistance, sponsored by National Institute of Mental Health (NIMH).
NCT01386476 is a study of Drug Resistance that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01386476, a study of Drug Resistance, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- The blood-brain barrier helps protect the brain from infections and toxins in the blood stream. But it can also prevent certain drugs from reaching the brain to treat diseases or other problems. Researchers are interested in chemicals that will help show how the barrier works. One possible chemical, (18F)FCWAY, may be useful for studying the barrier. More tests are needed to determine how effective it is. Objectives: \- To test whether (18F)FCWAY can be used to help study the blood-brain barrier. Eligibility: \- Healthy volunteers between 18 and 50 years of age. Design: * This study requires a screening visit and two scanning visits. * Participants will be screened with a physical exam and medical history. They will also have blood and urine tests. * At the first scanning visit, participants will have a magnetic resonance imaging scan to provide baseline images of the brain. * Before the second visit, some participants will stay overnight in the hospital. They will receive the drug tariquidar, which may help the (18F)FCWAY show the blood-brain barrier more clearly. * At the second scanning visit, all participants will have a positron emission tomography scan with (18F)FCWAY to see how well the drug shows the blood-brain barrier on the scan.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-06-15 |
| Est. Completion | 2016-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01386476
The ClinicalTrials.gov registry entry for NCT01386476 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Drug Resistance appearing as the primary indexed condition, and to 0 interventions.
NCT01386476 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01386476 about?
NCT01386476 is a clinical study titled "(18F)FCWAY and the Blood-Brain Barrier". Background: \- The blood-brain barrier helps protect the brain from infections and toxins in the blood stream. But it can also prevent certain drugs from reaching the brain to treat diseases or other problems. Researchers are interested in chemicals that will help show how the barrier works. One po...
What is the current status of trial NCT01386476?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2011-06-15. Estimated completion is 2016-09-01.
What conditions does trial NCT01386476 study?
This clinical trial studies the following conditions: Drug Resistance.
Who is sponsoring clinical trial NCT01386476?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01386476 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.